Anterogen.Co.,Ltd. (KOSDAQ:065660)
26,950
+100 (0.37%)
Jul 17, 2025, 9:40 AM KST
Anterogen.Co.,Ltd. Revenue
Anterogen.Co.,Ltd. had revenue of 1.60B KRW in the quarter ending March 31, 2025, with 4.56% growth. This brings the company's revenue in the last twelve months to 7.00B, up 7.90% year-over-year. In the year 2024, Anterogen.Co.,Ltd. had annual revenue of 6.93B with 6.66% growth.
Revenue (ttm)
7.00B
Revenue Growth
+7.90%
P/S Ratio
38.37
Revenue / Employee
n/a
Employees
n/a
Market Cap
268.66B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
PharmaResearch | 392.31B |
LigaChem Biosciences | 146.42B |